Preclinical Studies of Stem Cell Therapy for Heart Disease

被引：103

作者：

Tompkins, Bryon A. ^{[1
,2
]}

Balkan, Wayne ^{[1
,3
]}

Winkler, Johannes ^{[4
]}

Gyongyosi, Mariann ^{[4
]}

Goliasch, Georg ^{[4
]}

Fernandez-Aviles, Francisco ^{[5
,6
]}

Hare, Joshua M. ^{[1
,3
]}

机构：

[1] Univ Miami, Miller Sch Med, Interdisciplinary Stem Cell Inst, Biomed Res Bldg,1501 NW 10th Ave,Room 908, Miami, FL 33101 USA

[2] Univ Miami, Miller Sch Med, Dept Surg, Miami, FL 33101 USA

[3] Univ Miami, Miller Sch Med, Dept Med, Miami, FL 33101 USA

[4] Med Univ Vienna, Dept Cardiol, Vienna, Austria

[5] Univ Complutense, Inst Invest Sanitaria Gregorio Maranon, Hosp Gen Univ Gregorio Maranon, Madrid, Spain

[6] ISCIII, CIBERCV, Madrid, Spain

来源：

CIRCULATION RESEARCH | 2018年 / 122卷 / 07期

基金：

美国国家卫生研究院;

关键词：

heart failure; infarction; regenerative medicine; stem cells; ENDOTHELIAL PROGENITOR CELLS; BONE-MARROW-CELLS; ACUTE MYOCARDIAL-INFARCTION; IMPROVES CARDIAC-FUNCTION; ENHANCES COLLATERAL PERFUSION; MESENCHYMAL STROMAL CELLS; LEFT-VENTRICULAR FUNCTION; UMBILICAL-CORD BLOOD; DILATED CARDIOMYOPATHY; ISCHEMIC-HEART;

D O I：

10.1161/CIRCRESAHA.117.312486

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

As part of the TACTICS (Transnational Alliance for Regenerative Therapies in Cardiovascular Syndromes) series to enhance regenerative medicine, here, we discuss the role of preclinical studies designed to advance stem cell therapies for cardiovascular disease. The quality of this research has improved over the past 10 to 15 years and overall indicates that cell therapy promotes cardiac repair. However, many issues remain, including inability to provide complete cardiac recovery. Recent studies question the need for intact cells suggesting that harnessing what the cells release is the solution. Our contribution describes important breakthroughs and current directions in a cell-based approach to alleviating cardiovascular disease.

引用

页码：1006 / 1020

页数：15

共 50 条

[1] Concise Review: Review and Perspective of Cell Dosage and Routes of Administration From Preclinical and Clinical Studies of Stem Cell Therapy for Heart Disease
Golpanian, Samuel
Schulman, Ivonne H.
Ebert, Ray F.
Heldman, Alan W.
DiFede, Darcy L.
Yang, Phillip C.
Wu, Joseph C.
Bolli, Roberto
Perin, Emerson C.
Moye, Lem
Simari, Robert D.
Wolf, Ariel
Hare, Joshua M.
STEM CELLS TRANSLATIONAL MEDICINE, 2016, 5 (02) : 186 - 191
[2] Stem Cell Therapy for Heart Disease
Puliafico, Shannon B.
Penn, Marc S.
Silver, Kevin H.
JOURNAL OF GENERAL INTERNAL MEDICINE, 2013, 28 (10) : 1353 - 1363
[3] Stem Cell Therapy for Heart Disease
Shannon B. Puliafico
Marc S. Penn
Kevin H. Silver
Journal of General Internal Medicine, 2013, 28 : 1353 - 1363
[4] Mesenchymal stem cell therapy for heart disease
Gnecchi, Massimiliano
Danieli, Patrizia
Cervio, Elisabetta
VASCULAR PHARMACOLOGY, 2012, 57 (01) : 48 - 55
[5] Mesenchymal stem cell therapy in heart disease
Lopes, Joao Pedro
Fiarresga, Antonio
Cunha, Pedro Silva
Feliciano, Joana
Ferreira, Rui Cruz
REVISTA PORTUGUESA DE CARDIOLOGIA, 2013, 32 (01) : 43 - 47
[6] Stem Cell Therapy and Congenital Heart Disease
Nelson, Timothy J.
Peral, Susana Cantero
JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE, 2016, 3 (03):
[7] Stem Cell Therapy for Ischemic Heart Disease
Jameel, Mohammad Nurulqadr
Zhang, Jianyi
ANTIOXIDANTS & REDOX SIGNALING, 2010, 13 (12) : 1879 - 1897
[8] Stem cell therapy in ischemic heart disease
Sunkomat, JNE
Gaballa, MA
CARDIOVASCULAR DRUG REVIEWS, 2003, 21 (04): : 327 - 342
[9] Stem cell therapy for ischemic heart disease
Hassink, RJ
Dowell, JD
de la Rivière, AB
Doevendans, PA
Field, LJ
TRENDS IN MOLECULAR MEDICINE, 2003, 9 (10) : 436 - 441
[10] Challenges for heart disease stem cell therapy
Hoover-Plow, Jane
Gong, Yanqing
VASCULAR HEALTH AND RISK MANAGEMENT, 2012, 8 : 99 - 113

← 1 2 3 4 5 →